Literature DB >> 12448008

Socio-economic differences in incidence rates of cancers of the male genital organs in Finland, 1971-95.

Eero Pukkala1, Elisabete Weiderpass.   

Abstract

We studied social class variation in the incidence of cancers of the prostate, testis, penis and scrotum among 1.1 million Finnish men (45-69 years of age) during 1971-95. The incidence of prostate cancer (6,972 cases) was increasing during the study period; the highest at all the times occurred in Social Class I (highest social class), 40-50% higher than in Social Class IV (lowest). The social class gradient was strongest in localized disease but there was some variation in incidence of non-localized prostate cancer. A total of 174 testicular cancer cases were diagnosed during the study period. In the early 1970s, the incidence of testicular cancer in Social Class I was 5-fold compared to Social Classes III and IV. Thereafter, the incidence rate decreased in Social Class I, but increased in the lower classes. The positive social class gradient was similar for seminomas and non-seminomas. For penile cancer (n = 128), the incidence decreased over time and social class variation was small. Only 6 cases of scrotum cancer were observed. In testicular cancer the strong positive social class association in the early 1970s is disappearing along with converging incidence trend slopes in different social classes. The difference diminished to less than 2-fold in the 1990s. Reasons for this observation remain open. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12448008     DOI: 10.1002/ijc.10749

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

Review 1.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

2.  Regional variations in testicular cancer rates in Ireland.

Authors:  M Alsinnawi; M R Quinlan; S Deady; E A Kiely
Journal:  Ir J Med Sci       Date:  2010-11-19       Impact factor: 1.568

3.  Occupational class and the changing patterns of hospitalization for affective and neurotic disorders: a nationwide register-based study of the Finnish working-age population, 1976-2010.

Authors:  Pekka Varje; Anne Kouvonen; Lauri Kokkinen; Aki Koskinen; Ari Väänänen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-12-13       Impact factor: 4.328

Review 4.  Testicular cancer: a narrative review of the role of socioeconomic position from risk to survivorship.

Authors:  Lisa C Richardson; Antonio J Neri; Eric Tai; Jeffrey D Glenn
Journal:  Urol Oncol       Date:  2011-11-27       Impact factor: 3.498

5.  Increased risk of testicular germ cell cancer among infertile men.

Authors:  Thomas J Walsh; Mary S Croughan; Michael Schembri; June M Chan; Paul J Turek
Journal:  Arch Intern Med       Date:  2009-02-23

6.  Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007.

Authors:  George Kurdgelashvili; Graça M Dores; Samer A Srour; Anil K Chaturvedi; Mark M Huycke; Susan S Devesa
Journal:  Cancer       Date:  2013-04-11       Impact factor: 6.860

Review 7.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

8.  Differences in mortality and incidence for major sites of cancer by education level in a Japanese population.

Authors:  Nobuo Nishi; Hiromi Sugiyama; Wan-Ling Hsu; Midori Soda; Fumiyoshi Kasagi; Kiyohiko Mabuchi; Kazunori Kodama
Journal:  Ann Epidemiol       Date:  2008-05-16       Impact factor: 3.797

9.  Advanced testicular cancer in a society of racial and socio-economic health disparity.

Authors:  Michael Kaufman
Journal:  BMJ Case Rep       Date:  2013-06-24

10.  The impact of socio-economic circumstances on overall and grade-specific prostate cancer incidence: a population-based study.

Authors:  K Shafique; R Oliphant; D S Morrison
Journal:  Br J Cancer       Date:  2012-07-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.